PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells

Journal of Molecular Endocrinology

Volumn 53, Issue 2, 2014, Pages 247-258

  Morani, Federica ^a   Phadngam, Suratchanee ^a   Follo, Carlo ^a   Titone, Rossella ^a   Aimaretti, Gianluca ^a   Galetto, Alessandra ^a   Alabiso, Oscar ^a   Isidoro, Ciro ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Cancer; FDG PET imaging; Glucose; GLUT; PTEN; Warburg effect

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ARTICLE; CANCER CELL CULTURE; CELL MEMBRANE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENETIC MANIPULATION; GLUCOSE TRANSPORT; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; THYROID CANCER; THYROID CANCER CELL LINE; GENE EXPRESSION; GENETICS; HUMAN; INTRACELLULAR SPACE; METABOLISM; PHOSPHORYLATION; PROTEIN TRANSPORT; THYROID TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL MEMBRANE; GENE EXPRESSION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; HUMANS; INTRACELLULAR SPACE; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; THYROID NEOPLASMS;

EID: 84908001650     PISSN: 09525041     EISSN: 14796813     Source Type: Journal    
DOI: 10.1530/JME-14-0118     Document Type: Article

References (32)

1. Andrade BM, Cazarin J, Zancan P & Carvalho DP 2012 AMP-activated protein kinase upregulates glucose uptake in thyroid PCCL3 cells independent of thyrotropin. Thyroid 22 1063-1068. (doi:10.1089/thy.2012.0041)
2. Bertagna F, Treglia G, Piccardo A & Giubbini R 2012 Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. Journal of Clinical Endocrinology and Metabolism 97 3866-3875. (doi:10.1210/jc.2012-2390)
3. Bläser D, Maschauer S, Kuwert T & Prante O 2006 In vitro studies on the signal transduction of thyroidal uptake of 18F-FDG and 131I-Iodide. Journal of Nuclear Medicine 47 1382-1388.
4. Boellaard R, O’Doherty MJ, Weber WA, Mottaghy FM, Lonsdale MN, Stroobants SG, Oyen WJ, Kotzerke J, Hoekstra OS, Pruim J et al. 2010 FDG PET and PET/CT: EANM procedure guidelines for tumour PET imaging: version 1.0. European Journal of Nuclear Medicine and Molecular Imaging 37 181-200. (doi:10.1007/s00259-009-1297-4)
5. Bogsrud TV, Karantanis D, Nathan MA, Mullan BP, Wiseman GA, Kasperbauer JL, Reading CC, Björo T, Hay ID & Lowe VJ 2010 The prognostic value of 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography in patients with suspected residual or recurrent medullary thyroid carcinoma. Molecular Imaging and Biology 12 547-553. (doi:10.1007/s11307-009-0276-2)
6. Busk M, Horsman MR, Kristjansen PE, van der Kogel AJ, Bussink J & Overgaard J 2008 Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia. International Journal of Cancer 122 2726-2734. (doi:10.1002/ijc.23449)
7. Castino R, Bellio N, Nicotra G, Follo C, Trincheri NF & Isidoro C 2007 Cathepsin D-Bax death pathway in oxidative stressed neuroblastoma cells. Free Radical Biology & Medicine 42 1305-1316. (doi:10.1016/j.freeradbiomed.2006.12.030)
8. Ciampi R, Vivaldi A, Romei C, Del Guerra A, Salvadori P, Cosci B, Pinchera A & Elisei R 2008 Expression analysis of facilitative glucose transporters (GLUTs) in human thyroid carcinoma cell lines and primary tumors. Molecular and Cellular Endocrinology 291 57-62. (doi:10.1016/j.mce.2008.05.003)
9. Filetti S, Vetri M, Damante G & Belfiore A 1986 Thyroid autoregulation: effect of iodine on glucose transport in cultured thyroid cells. Endocrinology 118 1395-1400. (doi:10.1210/endo-118-4-1395)
10. Frilling A, Tecklenborg K, Görges R, Weber F, Clausen M & Broelsch EC 2001 Preoperative diagnostic value of [(18)F] fluorodeoxyglucose positron emission tomography in patients with radioiodine-negative recurrent well-differentiated thyroid carcinoma. Annals of Surgery 234 804-811. (doi:10.1097/00000658-200112000-00012)
11. Garcia-Cao I, Song MS, Hobbs RM, Laurent G, Giorgi C, de Boer VC, Anastasiou D, Ito K, Sasaki AT, Rameh L et al. 2012 Systemic elevation of PTEN induces a tumor-suppressive metabolic state. Cell 149 49-62. (doi:10.1016/j.cell.2012.02.030)
12. Grabellus F, Nagarajah J, Bockisch A, Schmid KW & Sheu SY 2012 Glucose transporter 1 expression, tumor proliferation, and iodine/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma. Clinical Nuclear Medicine 37 121-127. (doi:10.1097/RLU.0b013e3182393599)
13. Haber RS, Weiser KR, Pritsker A, Reder I & Burstein DE 1997 GLUT1 glucose transporter expression in benign and malignant thyroid nodules. Thyroid 7 363-367. (doi:10.1089/thy.1997.7.363)
14. Hosaka Y, Tawata M, Kurihara A, Ohtaka M, Endo T & Onaya T 1992 The regulation of two distinct glucose transporter (GLUT1 and GLUT4) gene expressions in cultured rat thyroid cells by thyrotropin. Endocrinology 131 159-165. (doi:10.1210/endo.131.1.1319316)
15. Hsiao YC, Wu PS, Chiu NT, Yao WJ, Lee BF & Peng SL 2011 The use of dual-phase 18F-FDG PET in characterizing thyroid incidentalomas. Clinical Radiology 66 1197-1202. (doi:10.1016/j.crad.2011.08.005)
16. Koppenol WH, Bounds PL & Dang CV 2011 Otto Warburg’s contributions to current concepts of cancer metabolism. Nature Reviews. Cancer 11 325-337. (doi:10.1038/nrc3038)
17. Matsuzu K, Segade F, Wong M, Clark OH, Perrier ND & Bowden DW 2005 Glucose transporters in the thyroid. Thyroid 15 545-550. (doi:10.1089/thy.2005.15.545)
18. Morani F, Pagano L, Prodam F, Aimaretti G & Isidoro C 2012 Loss of expression of the oncosuppressor PTEN in thyroid incidentalomas associates with GLUT1 plasmamembrane expression. Panminerva Medica 54 59-63.
19. Newsholme EA, Crabtree B & Ardawi MS 1985 The role of high rates of glycolysis and glutamine utilization in rapidly dividing cells. Bioscience Reports 5 393-400. (doi:10.1007/BF01116556)
20. O’Neil RG, Wu L & Mullani N 2005 Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells. Molecular Imaging and Biology 7 388-392. (doi:10.1007/s11307-005-0011-6)
21. Pagano L, Samà MT, Morani F, Prodam F, Rudoni M, Boldorini R, Valente G, Marzullo P, Baldelli R, Appetecchia M et al. 2011 Thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clinical Endocrinology 75 528-534. (doi:10.1111/j.1365-2265.2011. 04107.x)
22. Saiselet M, Floor S, Tarabichi M, Dom G, Hébrant A, van Staveren WC & Maenhaut C 2012 Thyroid cancer cell lines: an overview. Frontiers in Endocrinology 3 133. (doi:10.3389/fendo.2012.00133)
23. Saji M & Ringel MD 2010 The PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors. Molecular and Cellular Endocrinology 321 20-28. (doi:10.1016/j.mce.2009.10.016)
24. Samih N, Hovsepian S, Aouani A, Lombardo D & Fayet G 2000 Glut-1 translocation in FRTL-5 thyroid cells: role of phosphatidylinositol 3-kinase and N-glycosylation. Endocrinology 141 4146-4155. (doi:10.1210/endo.141.11.7793)
25. Semenza GL 2012 Hypoxia-inducible factors in physiology and medicine. Cell 148 399-408. (doi:10.1016/j.cell.2012.01.021)
26. Seo S, Hatano E, Higashi T, Nakajima A, Nakamoto Y, Tada M, Tamaki N, Iwaisako K, Kitamura K, Ikai I et al. 2009 P-glycoprotein expression affects 18F-fluorodeoxyglucose accumulation in hepatocellular carcinoma in vivo and in vitro. International Journal of Oncology 34 1303-1312. (doi:10.3892/ijo_00000257)
27. Szablewski L 2013 Expression of glucose transporters in cancers. Biochimica et Biophysica Acta 1835 164-169. (doi:10.1016/j.bbcan.2012.12.004)
28. Tong X, Zhao F, Mancuso A, Gruber JJ & Thompson CB 2009 The glucose-responsive transcription factor ChREBP contributes to glucose-dependent anabolic synthesis and cell proliferation. PNAS 106 21660-21665. (doi:10.1073/pnas.0911316106)
29. Trincheri NF, Nicotra G, Follo C, Castino R & Isidoro C 2007 Resveratrol induces cell death in colorectal cancer cells by a novel pathway involving lysosomal cathepsin D. Carcinogenesis 28 922-931. (doi:10.1093/carcin/bgl223)
30. Walker-Samuel S, Ramasawmy R, Torrealdea F, Rega M, Rajkumar V, Johnson SP, Richardson S, Gonçalves M, Parkes HG, Arstad E et al. 2013 In vivo imaging of glucose uptake and metabolism in tumors. Nature Medicine 19 1067-1072. (doi:10.1038/nm.3252)
31. Weng LP, Gimm O, Kum JB, Smith WM, Zhou XP, Wynford-Thomas D, Leone G & Eng C 2001 Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death. Human Molecular Genetics 10 251-258. (doi:10.1093/hmg/10.3.251)
32. Zundel W, Schindler C, Haas-Kogan D, Koong A, Kaper F, Chen E, Gottschalk AR, Ryan HE, Johnson RS, Jefferson AB et al. 2000 Loss of PTEN facilitates HIF-1-mediated gene expression. Genes and Development 14 391-396. (doi:10.1101/gad.14.4.391)